Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride in adult men with chronic constipation
NL-OMON39176Phase 3Active, not recruiting
- Sponsor
- Movetis
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic constipation comparing Prucalopride with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Feb 2011; status: active, not recruiting.
02
Drugs
prucalopride
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NL-OMON39176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39176.